Antiviral potentials of medicinal plants

Virus Research

Volumn 131, Issue 2, 2008, Pages 111-120

  Mukhtar, Muhammad ^a,d   Arshad, Mohammad ^b   Ahmad, Mahmood ^b   Pomerantz, Roger J ^c   Wigdahl, Brian ^d   Parveen, Zahida ^e  

^a PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

^b THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^c Tibotec Inc   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antivirals; Medicinal plants; Traditional medicine; Viral infections

Indexed keywords

ANTIVIRUS AGENT; AZADIRACHTA INDICA EXTRACT; BAICALIN; BLACK SOYBEAN EXTRACT; BOEHMERIA NIVEA EXTRACT; CARISSA EDULIS EXTRACT; CYANOVIRIN N; ELDERBERRY EXTRACT; FLAVONOID; GERANIIN; GERANIUM SANGUINEUM EXTRACT; GLUCOSIDE; GUAZUMA ULMIFOLIA EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA; LYCORIS RADIATE EXTRACT; OLIVE EXTRACT; PHYLLANTHUS AMARUS EXTRACT; PHYLLANTHUS URINARIA EXTRACT; PLANT EXTRACT; PODOPHYLLOTOXIN; POLYGONUM CUSPIDATUM EXTRACT; POLYPHENOL DERIVATIVE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAXIFRAGA MELANOCENTRA EXTRACT; STRYPHNODENDRON ADSTRINGENS EXTRACT; TRICHILIA GLABRA EXTRACT; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; AZADIRACHTA INDICA; BOEHMERIA NIVEA; CARISSA EDULIS; DRUG ISOLATION; GERANIUM SANGUINEUM; GUAZUMA ULMIFOLIA; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LIVER TOXICITY; LYCORIS RADIATE; MEDICINAL PLANT; NONHUMAN; OLIVE; OLIVE TREE; PHYLLANTHUS AMARUS; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; REVIEW; SAMBUCUS; SAXIFRAGA MELANOCENTRA; SOYBEAN; STRYPHNODENDRON ADSTRINGENS; TRADITIONAL MEDICINE; TRICHILIA GLABRA; VIRUS HEPATITIS; VIRUS INFECTION;

ANTIVIRAL AGENTS; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL; VIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38849181024     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.09.008     Document Type: Review

References (100)

1. Ahmad I., Aqil F., and Owais M. Modern Phytomedicine: Turning Medicinal Plants into Drugs. 1st ed. (2007), Wiley-VCH, Verlag GmbH & Co, KGaA, Weinheim
2. Andrighetti-Frohner C.R., Sincero T.C., da Silva A.C., Savi L.A., Gaido C.M., Bettega J.M., Mancini M., de Almeida M.T., Barbosa R.A., Farias M.R., Barardi C.R., and Simoes C.M. Antiviral evaluation of plants from Brazilian Atlantic Tropical Forest. Fitoterapia 76 3/4 (2005) 374-378
3. Anon. Traditional Medicine & HIV/AIDS in Africa. A report from the international conference on medicinal plants, traditional medicine & local communities in Africa. A Parallel Session to the Fifth Conference of the Parties to the Convention on Biological Diversity. Nairobi, Kenya, May 16-19, 2000 (2000)
4. Anon., 2005a. Medicinal plants-time to harness the potential of neglected genetic resources? Plant Genetic Resources: Characterization and Utilization. http://www.cabipublishing.org/pgr.
5. Anon., 2005b. A Practical Guide to Herbal Therapies for People Living with HIV. Canadian AIDS Treatment Information Exchange (CATIE).
6. Asres K., and Bucar F. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle. Ethiop. Med. J. 43 1 (2005) 15-20
7. Atta-ur-Rahman, and Choudhary M.I. New natural products from medicinal plants of Pakistan. Pure Appl. Chem. 70 (1998) 385-389
8. Barak V., Halperin T., and Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur. Cytokine Netw. 12 2 (2001) 290-296
9. Barrientos L.G., O'Keefe B.R., Bray M., Sanchez A., Gronenborn A.M., and Boyd M.R. Cyanovirin-N binds to the viral surface glycoprotein, GP120 and inhibits infectivity of Ebola virus. Antiviral Res. 58 1 (2003) 47-56
10. Bedows E., and Hatfield G.M. An investigation of the antiviral activity of Podophyllum peltatum. J. Nat. Prod. 45 6 (1982) 725-729
11. Bessong P.O., Rojas L.B., Obi L.C., Tshisikawe P.M., and Igunbor E.O. Further screening of Venda medicinal plants for activity against HIV type 1 reverse transcriptase and integrase. Afr. J. Biotechnol. 5 6 (2006) 526-528
12. Boyd M.R., Gustafson K.R., McMahon J.B., Shoemaker R.H., O'Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., Currens M.J., Cardellina II J.H., Buckheit Jr. R.W., Nara P.L., Pannell L.K., Sowder II R.C., and Henderson L.E. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41 7 (1997) 1521-1530
13. Buckwold V.E., Wilson R.J., Nalca A., Beer B.B., Voss T.G., Turpin J.A., Buckheit III R.W., Wei J., Wenzel-Mathers M., Walton E.M., Smith R.J., Pallansch M., Ward P., Wells J., Chuvala L., Sloane S., Paulman R., Russell J., Hartman T., and Ptak R. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res. 61 1 (2004) 57-62
14. Cella M., Riva D.A., Coulombie F.C., and Mersich S.E. Virucidal activity presence in Trichilia glabra leaves. Rev. Argent Microbiol. 36 3 (2004) 136-138
15. Chang J.S., Liu H.W., Wang K.C., Chen M.C., Chiang L.C., Hua Y.C., and Lin C.C. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res. 66 1 (2005) 29-34
16. Chantrill B.H., Coulthard C.E., Dickinson L., Inkley G.W., Morris W., and Pyle A.H. The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza A virus. J. Gen. Microbiol. 6 1-2 (1952) 74-84
17. Chiang L.C., Chiang W., Chang M.Y., and Lin C.C. In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. Am. J. Chin. Med. 31 2 (2003) 225-234
18. Cochran K.W., Nishikawa T., and Beneke E.S. Botanical sources of influenza inhibitors. Antimicrob. Agents Chemother. (Bethesda) 6 (1966) 515-520
19. De Clercq E. Emerging anti-HIV drugs. Expert Opin. Emerg. Drugs 10 2 (2005) 241-273
20. Debiaggi M., Pagani L., Cereda P.M., Landini P., and Romero E. Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2. Microbiologica 11 1 (1988) 55-61
21. Esimone C.O., Grunwald T., Wildner O., Nchinda G., Tippler B., Proksch P., and Uberla K. In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique. J. Appl. Microbiol. 99 6 (2005) 1346-1355
22. Esser M.T., Mori T., Mondor I., Sattentau Q.J., Dey B., Berger E.A., Boyd M.R., and Lifson J.D. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73 5 (1999) 4360-4371
23. Evstropov A.N., Burova L.G., Orlovskaia I.A., Grek O.R., Zakharova L.N., and Volkhonskaia T.A. Anti-enterovirus and immunostimulating activity of the polyphenol complex extracted from Pethaphylloides fruticosa (L.) O. Schwarz. Vopr. Virusol. 49 6 (2004) 30-33
24. Felipe A.M., Rincao V.P., Benati F.J., Linhares R.E., Galina K.J., de Toledo C.E., Lopes G.C., de Mello J.C., and Nozawa C. Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on Poliovirus and Bovine Herpesvirus. Biol. Pharm. Bull. 29 6 (2006) 1092-1095
25. Fu M., Ng T.B., Jiang Y., Pi Z.F., Liu Z.K., Li L., and Liu F. Compounds from rose (Rosa rugosa) flowers with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity. J. Pharm. Pharmacol. 58 9 (2006) 1275-1280
26. Glatthaar-Saalmuller B., Sacher F., and Esperester A. Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiviral Res. 50 3 (2001) 223-228
27. Glenz K., and Warzecha H. New medicinal plants for the production of vaccines. J. Verbr. Lebensm 1 (2006) 126-130
28. Hoareau L., and DaSilva E.J. Medicinal plants: a re-emerging health aid. Electr. J. Biotechnol. 2 2 (1999). http://www.ejb.org/content/vol2/issue2/full2
29. Houghton P.J., and Raman A. Laboratory Handbook for the Fractionation of Natural Extracts (1998), Chapman and Hall, New York
30. Huang K.L., Lai Y.K., Lin C.C., and Chang J.M. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. World J. Gastroenterol. 12 35 (2006) 5721-5725
31. Huang L., and Chen C.H. Molecular targets of anti-HIV-1 triterpenes. Curr. Drug Targets Infect. Disord. 2 1 (2002) 33-36
32. Hussein G., Miyashiro H., Nakamura N., Hattori M., Kakiuchi N., and Shimotohno K. Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother. Res. 14 7 (2000) 510-516
33. Hussein G., Miyashiro H., Nakamura N., Hattori M., Kawahata T., Otake T., Kakiuchi N., and Shimotohno K. Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease. Phytother. Res. 13 1 (1999) 31-36
34. Husson G.P., Vilagines P., Sarrette B., and Vilagines R. Study of antiviral action of total alkaloids from Haemanthus albiflos. Ann. Pharm. Fr. 52 6 (1994) 311-322
35. Ivanova E., Toshkova R., and Serkedjieva J. A plant polyphenol-rich extract restores the suppressed functions of phagocytes in influenza virus-infected mice. Microbes Infect. 7 3 (2005) 391-398
36. Jassim S.A.A., and Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 95 (2003) 412-427
37. Kitamura K., Honda M., Yoshizaki H., Yamamoto S., Nakane H., Fukushima M., Ono K., and Tokunaga T. Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res. 37 2 (1998) 131-140
38. Koprowski H., and Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine 19 (2001) 2735-2741
39. Kostova I. Coumarins as inhibitors of HIV reverse transcriptase. Curr. HIV Res. 4 3 (2006) 347-363
40. Kotwal G.J., Kaczmarek J.N., Leivers S., Ghebremariam Y.T., Kulkarni A.P., Bauer G., C D.E.B., Preiser W., and Mohamed A.R. Anti-HIV, anti-Poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium Species Secomet-V/anti-Vac suggests that it contains a novel broad-spectrum antiviral. Ann. NY Acad. Sci. 1056 (2005) 293-302
41. Kwon D.H., Kwon H.Y., Kim H.J., Chang E.J., Kim M.B., Yoon S.K., Song E.Y., Yoon D.Y., Lee Y.H., Choi I.S., and Choi Y.K. Inhibition of hepatitis B virus by an aqueous extract of Agrimonia eupatoria L. Phytother. Res. 19 4 (2005) 355-358
42. Lam W.Y., Leung K.T., Law P.T., Lee S.M., Chan H.L., Fung K.P., Ooi V.E., and Waye M.M. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis. J. Cell Biochem. 97 4 (2006) 795-812
43. Lee C.D., Ott M., Thyagarajan S.P., Shafritz D.A., Burk R.D., and Gupta S. Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. Eur. J. Clin. Invest. 26 12 (1996) 1069-1076
44. Lee-Huang S., Zhang L., Huang P.L., Chang Y.T., and Huang P.L. Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem. Biophys. Res. Commun. 307 4 (2003) 1029-1037
45. Leung K.T., Chiu L.C., Lam W.S., Li Y., Sun S.S., and Ooi V.E. In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus. Phytother. Res. 20 10 (2006) 911-914
46. Li B.Q., Fu T., Dongyan Y., Mikovits J.A., Ruscetti F.W., and Wang J.M. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem. Biophys. Res. Commun. 276 2 (2000) 534-538
47. Li S.Y., Chen C., Zhang H.Q., Guo H.Y., Wang H., Wang L., Zhang X., Hua S.N., Yu J., Xiao P.G., Li R.S., and Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 67 1 (2005) 18-23
48. Li Y., Yang Y., Fang L., Zhang Z., Jin J., and Zhang K. Anti-hepatitis activities in the broth of Ganoderma lucidum supplemented with a Chinese herbal medicine. Am. J. Chin. Med. 34 2 (2006) 341-349
49. Lin Z.J., Qiu S.X., Wufuer A., and Shum L. Simultaneous determination of glycyrrhizin, a marker component in radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 814 2 (2005) 201-207
50. Liu J., Manheimer E., Tsutani K., and Gluud C. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am. J. Gastroenterol. 98 3 (2003) 538-544
51. Ma J.K., Drake P.M., and Christou P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4 (2003) 794-805
52. May G., and Willuhn G. Antiviral effect of aqueous plant extracts in tissue culture. Arzneimittelforschung 28 1 (1978) 1-7
53. Melo F.L., Benati F.J., Junior W.A., de Mello J.C., Nozawa C., and Linhares R.E. The in vitro antivirial activity of an aliphatic nitro compound from Heteropteris aphrodisiaca. Microbiol. Res. (2006) (PMID: 16735108)
54. Micol V., Caturla N., Perez-Fons L., Mas V., Perez L., and Estepa A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res. 66 2/3 (2005) 129-136
55. Mothana R.A., Mentel R., Reiss C., and Lindequist U. Phytochemical screening and antiviral activity of some medicinal plants from the island Soqotra. Phytother. Res. 20 4 (2006) 298-302
56. Munshi A., Mehrotra R., and Panda S.K. Evaluation of Phyllanthus amarus and Phyllanthus maderaspatensis as agents for postexposure prophylaxis in neonatal duck hepatitis B virus infection. J. Med. Virol. 40 1 (1993) 53-58
57. Munshi A., Mehrotra R., Ramesh R., and Panda S.K. Evaluation of antihepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks. J. Med. Virol. 41 4 (1993) 275-281
58. Musch E., Chrissafidou A., and Malek M. Acute hepatitis due to kava-kava and St. John's Wort: an immune-mediated mechanism?. Dtsch. Med. Wochenschr 131 21 (2006) 1214-1217
59. Niu J.Z., Wang Y.Y., Qiao M., Gowans E., Edwards P., Thyagarajan S.P., Gust I., and Locarnini S. Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo. J. Med. Virol. 32 4 (1990) 212-218
60. Notka F., Meier G., and Wagner R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res. 64 2 (2004) 93-102
61. Olila D., Olwa O., and Opuda-Asibo J. Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro. Afr. Health Sci. 2 1 (2002) 2-10
62. Ong E.S. Extraction methods and chemical standardization of botanicals and herbal preparations. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 812 1/2 (2004) 23-33
63. Ooi L.S., Sun S.S., and Ooi V.E. Purification and characterization of a new antiviral protein from the leaves of Pandanus amaryllifolius (Pandanaceae). Int. J. Biochem. Cell Biol. 36 8 (2004) 1440-1446
64. Ott M., Thyagarajan S.P., and Gupta S. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur. J. Clin. Invest. 27 11 (1997) 908-915
65. Pak E., Esrason K.T., and Wu V.H. Hepatotoxicity of herbal remedies: an emerging dilemma. Prog. Transplant 14 2 (2004) 91-96
66. Pantev A., Ivancheva S., Staneva L., and Serkedjieva J. Biologically active constituents of a polyphenol extract from Geranium sanguineum L. with anti influenza activity. Z Naturforsch. [C] 61 7/8 (2006) 508-516
67. Paredes A., Hasegawa M., Prieto F., Mendez J., Rodriguez M., and Rodriguez-Ortega M. Biological activity of Guatteria cardoniana fractions. J. Ethnopharmacol. 78 2/3 (2001) 129-132
68. Parida M.M., Upadhyay C., Pandya G., and Jana A.M. Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. J. Ethnopharmacol. 79 2 (2002) 273-278
69. Park J.C., Kim S.C., Choi M.R., Song S.H., Yoo E.J., Kim S.H., Miyashiro H., and Hattori M. Anti-HIV protease activity from rosa family plant extracts and rosamultin from Rosa rugosa. J. Med. Food 8 1 (2005) 107-109
70. Patrick L. Hepatitis C: epidemiology and review of complementary/alternative medicine treatments. Altern. Med. Rev. 4 (1999) 220-238
71. Pompei R., Flore O., Marccialis M.A., Pani A., and Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281 5733 (1979) 689-690
72. Prahoveanu E., Esanu V., Anton G., and Frunzulica S. Prophylactic effect of a Beta vulgaris extract on experimental influenza infection in mice. Virologie 37 2 (1986) 121-123
73. Prajoubklang A., Sirithunyalug B., Charoenchai P., Suvannakad R., Sriubolmas N., Piyamongkol S., Kongsaeree P., and Kittakoop P. Bioactive deoxypreussomerins and dimeric naphthoquinones from Diospyros ehretioides fruits: deoxypreussomerins may not be plant metabolites but may be from fungal epiphytes or endophytes. Chem. Biodivers. 2 10 (2005) 1358-1367
74. Schiano T.D. Hepatotoxicity and complementary and alternative medicines. Clin. Liver Dis. 7 2 (2003) 453-473
75. Serkedjieva J. Anti-infective activity of a plant preparation from Geranium sanguineum L. Pharmazie 52 10 (1997) 799-802
76. Serkedjieva J. Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L. Pharmazie 58 1 (2003) 53-57
77. Sindambiwe J.B., Calomme M., Cos P., Totte J., Pieters L., Vlietinck A., and Vanden Berghe D. Screening of seven selected Rwandan medicinal plants for antimicrobial and antiviral activities. J. Ethnopharmacol. 65 1 (1999) 71-77
78. Siow Y.L., Gong Y., Au-Yeung K.K., Woo C.W., Choy P.C., and O K. Emerging issues in traditional Chinese medicine. Can. J. Physiol. Pharmacol. 83 4 (2005) 321-334
79. Su M., Li Y., Leung K.T., Cen Y., Li T., Chen R., and Ooi V.E. Antiviral activity and constituent of Ardisia chinensis benth against coxsackie B3 virus. Phytother. Res. 20 8 (2006) 634-639
80. Takahashi K., Matsuda M., Ohashi K., Taniguchi K., Nakagomi O., Abe Y., Mori S., Sato N., Okutani K., and Shigeta S. Analysis of anti-rotavirus activity of extract from Stevia rebaudiana. Antiviral Res. 49 1 (2001) 15-24
81. Thanavala Y., Mahoney M., Pal S., Scott A., Richter L., Natarajan N., Goodwin P., Arntzen C., and Mason H. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 3378-3382
82. Tolo F.M., Rukunga G.M., Muli F.W., Njagi E.N., Njue W., Kumon K., Mungai G.M., Muthaura C.N., Muli J.M., Keter L.K., Oishi E., and Kofi-Tsekpo M.W. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus. J. Ethnopharmacol. 104 1/2 (2006) 92-99
83. Vermani K., and Garg S. Herbal medicines for sexually transmitted diseases and AIDS. J. Ethnopharmacol. 80 1 (2002) 49-66
84. Vilagines P., Delaveau P., and Vilagines R. Inhibition of poliovirus replication by an extract of Matricaria chamomilla (L). C. R. Acad. Sci. III 301 6 (1985) 289-294
85. Wagner H., Bladt S., and Ricki V. Plant Drug Analysis: A Thin Layer Chromatography. 2nd ed. (1996), Springer, New York
86. Wang M., Cheng H., Li Y., Meng L., Zhao G., and Mai K. Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites. J. Lab. Clin. Med. 126 4 (1995) 350-352
87. Wang Q., Wang Y.T., Pu S.P., and Zheng Y.T. Zinc coupling potentiates anti-HIV-1 activity of baicalin. Biochem. Biophys. Res. Commun. 324 2 (2004) 605-610
88. Wang W.N., Yang X.B., Liu H.Z., Huang Z.M., and Wu G.X. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection. Acta Pharmacol. Sin. 26 5 (2005) 587-592
89. Wang X., Jia W., Zhao A., and Wang X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 20 5 (2006) 335-341
90. Webster D., Taschereau P., Lee T.D., and Jurgens T. Immunostimulant properties of Heracleum maximum Bartr. J. Ethnopharmacol. 106 3 (2006) 360-363
91. Witvrouw M., Fikkert V., Hantson A., Pannecouque C., O'Keefe B.R., McMahon J., Stamatatos L., de Clercq E., and Bolmstedt A. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J. Virol. 79 12 (2005) 7777-7784
92. Woradulayapinij W., Soonthornchareonnon N., and Wiwat C. In vitro HIV type 1 reverse transcriptase inhibitory activities of Thai medicinal plants and Canna indica L. rhizomes. J. Ethnopharmacol. 101 1-3 (2005) 84-89
93. Wu W., Liang Z., Zhao Z., and Cai Z. Direct analysis of alkaloid profiling in plant tissue by using matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 42 1 (2007) 58-69
94. Yamai M., Tsumura K., Kimura M., Fukuda S., Murakami T., and Kimura Y. Antiviral activity of a hot water extract of black soybean against a human respiratory illness virus. Biosci. Biotechnol. Biochem. 67 5 (2003) 1071-1079
95. Yang C.M., Cheng H.Y., Lin T.C., Chiang L.C., and Lin C.C. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J. Ethnopharmacol. 110 3 (2007) 555-558
96. Yu D., Sakurai Y., Chen C.H., Chang F.R., Huang L., Kashiwada Y., and Lee K.H. Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents. J. Med. Chem. 49 18 (2006) 5462-5469
97. Yu D., Wild C.T., Martin D.E., Morris-Natschke S.L., Chen C.H., Allaway G.P., and Lee K.H. The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV. Expert Opin. Investig. Drugs 14 6 (2005) 681-693
98. Zakay-Rones Z., Thom E., Wollan T., and Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J. Int. Med. Res. 32 2 (2004) 132-140
99. Zhang X., Tang X., and Chen H. Inhibition of HIV replication by baicalin and S. baicalensis extracts in H9 cell culture. Chin. Med. Sci. J. 6 4 (1991) 230-232
100. Zuo G.Y., Li Z.Q., Chen L.R., and Xu X.J. In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antivir. Chem. Chemother. 16 6 (2005) 393-398